Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Avalon Globocare (AVCO)

Avalon Globocare (AVCO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 119,536
  • Shares Outstanding, K 75,656
  • Annual Sales, $ 1,560 K
  • Annual Income, $ -7,770 K
  • 60-Month Beta 0.77
  • Price/Sales 70.23
  • Price/Cash Flow N/A
  • Price/Book 12.84

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.41 +11.35%
on 11/13/19
1.74 -9.77%
on 10/21/19
-0.04 (-2.48%)
since 10/15/19
3-Month
1.41 +11.35%
on 11/13/19
2.65 -40.75%
on 09/17/19
-0.26 (-14.21%)
since 08/15/19
52-Week
1.41 +11.35%
on 11/13/19
13.50 -88.37%
on 01/22/19
-1.21 (-43.53%)
since 11/14/18

Most Recent Stories

More News
Orbia Announces Third Quarter 2019 Financial Results

-Orbia Advance Corporation, S.A.B. de C.V. (BMV: ORBIA*) ("the Company" or "Orbia") today released unaudited results for the third quarter of 2019.

AVCO : 1.57 (-0.63%)
Avalon GloboCare Enters Agreement to Repurchase 100% of Outstanding Warrants

Avalon GloboCare Corp. (NASDAQ: AVCO), a leading global developer of cell-based technologies and therapeutics, today announced plans to repurchase all of the Company's outstanding warrants, totaling approximately...

AVCO : 1.57 (-0.63%)
Orbia Announces Conference Call For Its Third Quarter 2019 Earnings Results

Orbia Advance Corporation, S.A.B. de C.V. (BMV: ORBIA*) will release its third quarter 2019 earnings results after the market closes on Wednesday, October 23, 2019.

AVCO : 1.57 (-0.63%)
Avalon GloboCare Announces Initiation of First-in-Human Clinical Trial of its CAR-T Candidate, AVA-001, for Treatment of B-Cell Malignancies

Avalon GloboCare Corp. (NASDAQ: AVCO), a leading global developer of cell-based technologies and therapeutics, today announced it has initiated its first-in-human, Phase I clinical trial of CD19 Chimeric...

AVCO : 1.57 (-0.63%)
Avalon GloboCare Announces $20 Million Credit Facility Provided by Company Chairman

Avalon GloboCare Corp. (NASDAQ: AVCO), a leading clinical-stage global developer of cell-based technologies and therapeutics, today announced it has secured a $20 million credit facility provided by the...

AVCO : 1.57 (-0.63%)
Avalon GloboCare and GE Healthcare Announce Strategic Partnership to Accelerate Standardized Automation and Bio-production for Cellular Medicines

Avalon GloboCare Corp. (NASDAQ: AVCO), a leading clinical-stage global developer of cell-based technologies and therapeutics, today announced that they have established a strategic partnership with GE...

AVCO : 1.57 (-0.63%)
Geron Enhances Oncology Expertise to Advance Corporate Objectives

Geron Corporation (Nasdaq: GERN) today announced the appointments of Sharon McBain as Vice President, Global Regulatory Affairs and Lynn Bodarky as Vice President, Business Development. These appointments...

AVCO : 1.57 (-0.63%)
GERN : 1.31 (-4.38%)
Avalon GloboCare Provides Updates on its Lead Clinical Programs in CAR-T Therapy and Exosome-Based Regenerative Therapeutics

Avalon GloboCare Corp. (NASDAQ: AVCO), a leading global developer of cell-based technologies and therapeutics, today announced an update on its four clinical programs in cellular therapy, including AVA-001...

AVCO : 1.57 (-0.63%)
Avalon GloboCare Appoints Dr. Yen-Michael Sheng Hsu, Founding Director of cGMP Cellular Therapy Facility at Weill Cornell Medicine, to its Scientific and Clinical Advisory Board

Avalon GloboCare Corp. (NASDAQ: AVCO), a leading global developer of cell-based technologies and therapeutics, announced today that the Company has appointed Yen-Michael S. Hsu, M.D., Ph.D. to its Scientific...

AVCO : 1.57 (-0.63%)
Avalon GloboCare Announces Completion of Clinical-Grade Exosome Bio-Production Standardization with Launch of "ACTEX" Product Commercialization

Avalon GloboCare Corp. (NASDAQ: AVCO), a leading global developer of cell-based technologies and therapeutics, today announced it has achieved a major milestone in bio-production standardization of clinical-grade...

AVCO : 1.57 (-0.63%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade AVCO with:

Business Summary

Avalon GloboCare Corp. outsourced healthcare services. It serves healthcare institutions, individual patients, academia and corporations sector. The company provides healthcare management which comprises cell-based technologies and therapeutics, genomic diagnostics and precision medicine, international...

See More

Key Turning Points

2nd Resistance Point 1.65
1st Resistance Point 1.61
Last Price 1.57
1st Support Level 1.54
2nd Support Level 1.51

See More

52-Week High 13.50
Fibonacci 61.8% 8.88
Fibonacci 50% 7.45
Fibonacci 38.2% 6.03
Last Price 1.57
52-Week Low 1.41

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar